V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 160017174 | 160019271 | 0 | 65.6 | Palliative (P) | 2018-09-16 | 2019-03-31 | LUTETIUM-177 | N | N | NAB-PACLITAXEL | 100074163 |
| 160017176 | 160019272 | null | 30.8 | Adjuvant (A) | 2019-10-14 | 2020-06-01 | Methotrexate intrathecal | 02 | N | BEVACIZUMAB + CISPLATIN + PEMETREXED | 100445707 |
| 160017182 | 160019273 | 1.61 | 13.9 | null | 2021-08-24 | 2021-09-05 | STS Rhabdo VIT0910 Vinc Irino Temoz | 01 | null | TEMOZOLOMIDE | 100369669 |
| 160017194 | 160019274 | 0 | 108 | null | 2020-02-10 | 2020-05-11 | STS Rhabdomyosarcoma RMS 2005 IVA | 02 | null | NOT MATCHED | 101188298 |
| 160017196 | 160019275 | 1.65 | 118.6 | null | null | 2018-09-25 | EW EuroEwing 2012 Arm B VC | 01 | null | GEMCITABINE | 100729238 |
| 160017216 | 160019277 | 1.67 | 70.3 | Palliative (P) | 2018-12-03 | 2019-02-18 | NB HRNBL-1 COJEC Ind COURSE B | 02 | N | STS RHABDOMYOSARCOMA RMS 2005 IVA | 101196585 |
| 160017219 | 160019278 | 1.73 | 80.55 | Palliative (P) | 2016-12-02 | 2016-12-05 | Ifosfamide | 01 | N | NIRAPARIB | 101529211 |
| 160017222 | 160019280 | 1.58 | 86 | null | 2019-10-31 | 2019-11-06 | CABOZANTINIB | 02 | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + VINCRISTINE | 100311295 |
| 160017227 | 160019281 | 0 | 12 | Curative (C) | 2018-12-30 | 2019-01-16 | Olaparib | 01 | N | DARATUMUMAB | 100296549 |
| 160017260 | 160019283 | 1.79 | 109.6 | null | 2019-06-05 | 2020-03-07 | Doxorubicin + Ifosfamide | 02 | null | NOT MATCHED | 100969350 |
| 160017277 | 160019284 | 1.88 | 12.3 | Curative (C) | null | 2022-01-27 | STS Rhabdo VIT0910 Vinc Irino Temoz | 02 | N | RUCAPARIB | 100030899 |
| 160017287 | 160019285 | 1.74 | 86.2 | Palliative (P) | 2016-12-17 | 2017-06-19 | null | 02 | N | NB HRNBL-1 BUMEL MAT | 101651506 |
| 160017297 | 160019286 | 1.87 | 72.4 | Curative (C) | 2019-11-11 | 2019-11-12 | STS Rhabdo RMS 2005 Vin Cyclo | 02 | N | NOT MATCHED | 101018565 |
| 160017314 | 160019287 | 1.89 | 75.8 | null | null | null | EW Rel rEECur Irinotecan/Temozolomide | 02 | null | NOT MATCHED | 101633755 |
| 160017328 | 160019288 | 1.77 | 100 | Palliative (P) | 2020-10-06 | 2020-11-03 | EW Rel rEECur Topotecan/Cyclophosphamide | 02 | N | STS NON-RHABDO EPSSG 2005 IVA | 101659424 |
| 160017330 | 160019289 | null | null | Curative (C) | 2018-10-29 | 2018-11-26 | Cyclophosphamide PO +Vinorelbine IV | N | N | STS RHABDO VIT0910 VINC IRINOTECAN | 101791368 |
| 160017335 | 160019290 | 1.75 | 148 | null | 2019-06-04 | 2019-06-17 | STS Rhabdo RMS 2005 Vin Cyclo | 02 | null | DOXORUBICIN + IFOSFAMIDE | 100789822 |
| 160017358 | 160019291 | 1.58 | 69 | Palliative (P) | 2017-07-31 | 2017-08-07 | Carboplatin + Vinorelbine IV | 02 | N | NOT MATCHED | 100480278 |
| 160017375 | 160019292 | 1.56 | 88.1 | Palliative (P) | 2019-12-21 | 2020-02-01 | VINCRISTINE | 02 | N | EW EUROEWING 2012 ARM B IE | 101613656 |
| 160017378 | 160019293 | 1.5 | 107.4 | Curative (C) | 2018-11-02 | 2018-12-04 | BEVACIZUMAB + CARBO + PACLITAXEL | 02 | N | MELPHALAN | 100810764 |
| 160017385 | 160019294 | null | null | Curative (C) | null | 2018-08-17 | null | 02 | N | CYCLOPHOSPHAMIDE | 100674697 |
| 160017388 | 160019295 | 1.78 | 11.8 | Curative (C) | 2021-01-29 | 2021-01-30 | GEMCITABINE | 02 | N | EW EUROEWING 2012 ARM B IE | 101109548 |
| 160017396 | 160019296 | 1.8 | 41 | Palliative (P) | null | 2021-02-21 | IVADo | 02 | N | FLUOROURACIL + IRINOTECAN | 101280426 |
| 160017418 | 160019297 | 1.77 | 33.8 | null | 2020-12-14 | 2020-12-20 | EW EuroEwing 2012 Arm B VC | 02 | null | TRIAL | 100627889 |
| 160017419 | 160019298 | 1.62 | 98.2 | Neo-adjuvant (N) | 2016-07-16 | 2016-08-05 | IVA | 02 | N | CYCLOPHOSPHAMIDE | 100343892 |
| 160017422 | 160019299 | 1.57 | 63.5 | Curative (C) | null | 2020-05-12 | NB HRNBL-1 MOD N7 PE | 01 | N | EW EUROEWING 2012 ARM B VC | 100534873 |
| 160017434 | 160019300 | 1.61 | 12.6 | null | 2020-10-20 | 2022-02-12 | GEMCITABINE | 01 | null | TAZEMETOSTAT | 100288250 |
| 160017435 | 160019301 | 1.9 | 86.2 | null | 2019-10-16 | 2019-10-19 | ETOP 13-18 BEAT-meso Trial | 02 | null | DACTINOMYCIN + IFOSFAMIDE + VINCRISTINE | 100270980 |
| 160017444 | 160019302 | 1.63 | 15.6 | Palliative (P) | 2021-03-05 | 2021-03-06 | Rucaparib | 01 | N | NB LOW/INTERM RISK GUIDELINES CARBO/ETOP | 100126331 |
| 160017454 | 160019303 | 1.82 | 114.3 | null | 2017-10-06 | 2017-10-07 | NB HRNBL | 02 | null | DOXORUBICIN + IFOSFAMIDE | 100695137 |
| 160017457 | 160019304 | 1.71 | null | Curative (C) | 2018-12-02 | 2019-05-09 | Cyclophosphamide oral | 02 | N | NB HRNBL-1 BUMEL MAT | 100866679 |
| 160017466 | 160019305 | 0 | 50.6 | Curative (C) | 2017-12-03 | 2017-12-17 | CYCLOPHOSPHAMIDE + VINORELBINE | 02 | N | CARBOPLATIN + VINORELBINE | 101683920 |
| 160017476 | 160019306 | 1.54 | 108 | Not known (9) | 2018-03-09 | 2018-03-13 | Olaparib | 02 | N | GEMCITABINE | 101680592 |
| 160017490 | 160019307 | 1.75 | 74.5 | null | 2016-12-21 | 2019-03-30 | EW EuroEwing 2012 Arm B VC | N | null | NB HRNBL-1 ISOTRETINOIN | 100770715 |
| 160017495 | 160019308 | 1.56 | 14.7 | null | 2017-09-10 | 2019-06-01 | ATOMIC-MESO TRIAL | 02 | null | LAROTRECTINIB | 100568199 |
| 160017548 | 160019309 | 1.67 | 76.5 | 03 | 2016-07-29 | 2016-10-27 | Cisplatin + Gemcitabine (D 1 & 8) | 02 | N | ETOPOSIDE + RITUXIMAB | 100915208 |
| 160017554 | 160019310 | null | 73.1 | 03 | 2020-06-18 | 2020-06-25 | Cyclophosphamide + Vincristine | 01 | N | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL | 101244428 |
| 160017556 | 160019311 | 1.65 | 51 | Curative (C) | 2021-12-28 | 2021-12-28 | IRINOTECAN + TEMOZOLOMIDE + VINCRISTINE | 02 | N | STS RHABDOMYOSARCO RMS 2005 IVADOVV | 101502820 |
| 160017573 | 160019312 | 1.67 | 52.41 | Neo-adjuvant (N) | 2016-06-16 | 2016-06-17 | EW EuroEwing 2012 Arm B IE | null | N | GEMCITABINE | 100093601 |
| 160017581 | 160019313 | 1.56 | 62 | null | 2018-02-04 | 2018-02-21 | VAI (Ifos 3g/m2) | Y | null | CAPECITABINE + EPIRUBICIN + OXALIPLATIN | 101161754 |
| 160017582 | 160019314 | 1.78 | 13.2 | Curative (C) | 2019-08-26 | 2019-09-29 | Niraparib | 02 | N | CARBOPLATIN + FLUOROURACIL | 101358586 |
| 160017589 | 160019315 | 1.82 | 53.7 | null | 2016-08-04 | 2016-09-05 | VINCRISTINE | 02 | null | DOXORUBICIN + IFOSFAMIDE | 101010455 |
| 160001486 | 160019317 | 1.86 | 59.8 | null | 2020-03-23 | 2020-03-31 | Doxorubicin + Ifosfamide | 02 | null | GEMCITABINE | 101068815 |
| 160001867 | 160019318 | 1.71 | 0 | null | 2018-10-05 | 2018-10-11 | STS Rhabdo RMS 2005 Vin Cyclo | 2 | null | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL | 100608098 |
| 160002009 | 160019319 | 1.64 | 96.75 | Palliative (P) | 2020-06-21 | 2020-06-21 | EW EuroEwing 2012 Arm B VC | 02 | N | CYCLOPHOSPHAMIDE | 100169851 |
| 160002663 | 160019320 | 1.66 | 91.2 | Curative (C) | 2020-07-03 | 2020-07-03 | null | 01 | N | TRIAL | 100494391 |
| 160003704 | 160019321 | 1.58 | 104 | Palliative (P) | 2016-11-20 | 2016-11-23 | Abiraterone | 02 | N | EW EUROEWING 2012 ARM B IE | 101329324 |
| 160005199 | 160019323 | 1.82 | 34 | null | 2019-10-29 | 2019-11-06 | Gemcitabine day 1&8 | 02 | null | NOT MATCHED | 100797738 |
| 160006388 | 160019324 | 1.65 | 68.6 | null | 2017-02-24 | 2017-02-24 | GEMCITABINE | 02 | null | PEMETREXED | 101297123 |
| 160006389 | 160019325 | 1.77 | 13.1 | 03 | 2021-03-04 | 2021-04-30 | NB BEACON Temozolomide Irinotecan | 02 | N | OST M | 100953709 |